Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way

Archives of Oral Biology

Volumn 55, Issue 3, 2010, Pages 185-194

  Dohan Ehrenfest, David M ^a,b   Doglioli, Pierre ^c   de Peppo, Giuseppe M ^a   Del Corso, Marco ^b   Charrier, Jean Baptiste ^b,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LoB5 Foundation for Research   (France)

^c Cell Culture Laboratory   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Coculture; Growth factors; Leukocyte; Mesenchymal stem cell; Platelet concentrate; Platelet rich fibrin (PRF); Platelet rich plasma (PRP)

Indexed keywords

ALKALINE PHOSPHATASE; BIOMATERIAL; COLORING AGENT; DIAGNOSTIC AGENT; FIBRIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRYPAN BLUE;

ARTICLE; BONE MINERALIZATION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; CYTOLOGY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG EFFECT; HUMAN; LEUKOCYTE; MALE; MAXILLA; MESENCHYMAL STEM CELL; METHODOLOGY; MIDDLE AGED; OSTEOBLAST; OSTEOTOMY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; THROMBOCYTE; TIME; TRANSPLANTATION;

ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CALCIFICATION, PHYSIOLOGIC; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; COLORING AGENTS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN; HUMANS; LEUKOCYTES; MALE; MAXILLA; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; OSTEOBLASTS; OSTEOTOMY; SPECTROPHOTOMETRY; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TRYPAN BLUE;

EID: 77649234169     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.01.004     Document Type: Article

References (55)

1. Dohan Ehrenfest D.M., Rasmusson L., and Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27 3 (2009) 158-167
2. Dohan D.M., and Choukroun J. PRP, cPRP, PRF, PRG, PRGF, FC. How to find your way in the jungle of platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 3 (2007) 305-306
3. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., and Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 6 (1998) 638-646
4. Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J., Mouhyi J., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) e37-e44
5. Keceli H.G., Sengun D., Berberoglu A., and Karabulut E. Use of platelet gel with connective tissue grafts for root coverage: a randomized-controlled trial. J Clin Periodontol 35 3 (2008) 255-262
6. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., and Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17 2 (2006) 212-219
7. Cenni E., Ciapetti G., Pagani S., Perut F., Giunti A., and Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 76 3 (2005) 323-328
8. Yamada Y., Ueda M., Naiki T., Takahashi M., Hata K., and Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10 5-6 (2004) 955-964
9. Oliva A., Passaro I., Di Pasquale R., Di Feo A., Criscuolo M., Zappia V., et al. Ex vivo expansion of bone marrow stromal cells by platelet-rich plasma: a promising strategy in maxillo-facial surgery. Int J Immunopathol Pharmacol 18 3 Suppl. (2005) 47-53
10. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205 2 (2005) 228-236
11. Yamada Y., Ueda M., Hibi H., and Nagasaka T. Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 13 4 (2004) 343-355
12. Yamada Y., Ueda M., Naiki T., and Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implants Res 15 5 (2004) 589-597
13. Ohya M., Yamada Y., Ozawa R., Ito K., Takahashi M., and Ueda M. Sinus floor elevation applied tissue-engineered bone. Comparative study between mesenchymal stem cells/platelet-rich plasma (PRP) and autogenous bone with PRP complexes in rabbits. Clin Oral Implants Res 16 5 (2005) 622-629
14. Kinoshita K., Hibi H., Yamada Y., and Ueda M. Promoted new bone formation in maxillary distraction osteogenesis using a tissue-engineered osteogenic material. J Craniofac Surg 19 1 (2008) 80-87
15. Ueda M., Yamada Y., Ozawa R., and Okazaki Y. Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement. Int J Periodontics Restorative Dent 25 2 (2005) 129-137
16. Kitoh H., Kitakoji T., Tsuchiya H., Katoh M., and Ishiguro N. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40 2 (2007) 522-528
17. Kitoh H., Kitakoji T., Tsuchiya H., Mitsuyama H., Nakamura H., Katoh M., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 35 4 (2004) 892-898
18. Kasten P., Vogel J., Luginbuhl R., Niemeyer P., Weiss S., Schneider S., et al. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 183 2 (2006) 68-79
19. Dallari D., Fini M., Stagni C., Torricelli P., Nicoli Aldini N., Giavaresi G., et al. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 24 5 (2006) 877-888
20. Filho Cerruti H., Kerkis I., Kerkis A., Tatsui N.H., da Costa Neves A., Bueno D.F., et al. Allogenous bone grafts improved by bone marrow stem cells and platelet growth factors: clinical case reports. Artif Organs 31 4 (2007) 268-273
21. Lucarelli E., Fini M., Beccheroni A., Giavaresi G., Di Bella C., Aldini N.N., et al. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res 435 (2005) 62-68
22. Arpornmaeklong P., Kochel M., Depprich R., Kubler N.R., and Wurzler K.K. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33 1 (2004) 60-70
23. Vogel J.P., Szalay K., Geiger F., Kramer M., Richter W., and Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 17 7 (2006) 462-469
24. Lucarelli E., Beccheroni A., Donati D., Sangiorgi L., Cenacchi A., Del Vento A.M., et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24 18 (2003) 3095-3100
25. Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J., Mouhyi J., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) e45-50
26. Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J., Mouhyi J., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) e51-e55
27. Choukroun J., Adda F., Schoeffler C., and Vervelle A. Une opportunité en paro-implantologie: le PRF. Implantodontie 42 (2001) 55-62
28. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun's Platelet-Rich Fibrin (PRF) clot and membrane. J Periodontol; in press.
29. Dohan Ehrenfest D.M., De Peppo G.M., Doglioli P., and Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27 1 (2009) 63-69
30. Dohan Ehrenfest D.M., Diss A., Odin G., Doglioli P., Hippolyte M.P., and Charrier J.B. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 3 (2009) 341-352
31. Choukroun J., Diss A., Simonpieri A., Girard M.O., Schoeffler C., Dohan S.L., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) e56-e60
32. Choukroun J., Diss A., Simonpieri A., Girard M.O., Schoeffler C., Dohan S.L., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) 299-303
33. Saadoun A.P., and Touati B. Soft tissue recession around implants: is it still unavoidable? Part II. Pract Proced Aesthet Dent 19 2 (2007) 81-87 [quiz 8]
34. Diss A., Dohan D.M., Mouhyi J., and Mahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 5 (2008) 572-579
35. Simonpieri A., Del Corso M., Sammartino G., and Dohan Ehrenfest D.M. The relevance of Choukroun's platelet rich fibrin (PRF) and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: a new grafting protocol. Implant Dent 18 2 (2009) 102-111
36. Simonpieri A., Del Corso M., Sammartino G., and Dohan Ehrenfest D.M. The relevance of Choukroun's platelet-rich fibrin (PRF) and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics and survival. Implant Dent 18 3 (2009) 220-229
37. Choukroun J.I., Braccini F., Diss A., Giordano G., Doglioli P., and Dohan D.M. Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: a new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?. Rev Laryngol Otol Rhinol (Bord) 128 1-2 (2007) 27-32
38. Braccini F., and Dohan D.M. The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): preliminary results. Rev Laryngol Otol Rhinol (Bord) 128 4 (2007) 255-260
39. Charrier J.B., Monteil J.P., Albert S., Collon S., Bobin S., and Dohan Ehrenfest D.M. Relevance of Choukroun's platelet-rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: a new technique. Rev Laryngol Otol Rhinol (Bord) 129 5 (2008) 313-318
40. Mazor Z., Horowitz R.A., Del Corso M., Prasad H.S., Rohrer M.D., and Dohan Ehrenfest D.M. Sinus floor augmentation with simultaneous implant placement using Choukroun's PRF (platelet-rich fibrin) as sole grafting material: a radiological and histological study at 6 months. J Periodontol 80 12 (2009) 2056-2064
41. Del Corso M., Sammartino G., and Dohan Ehrenfest D.M. Choukroun's platelet-rich fibrin (PRF) membranes in periodontal surgery: understanding the biomaterial or believing into the magic of growth factors?. J Periodontol 80 11 (2009) 1694-1697
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 1-2 (1983) 55-63
43. Dohan D.M., Del Corso M., and Charrier J.-B. Cytotoxicity analyses of Choukroun's PRF (platelet rich fibrin) on a wide range of human cells: the answer to a commercial controversy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 5 (2007) 587-593
44. He L., Lin Y., Hu X., Zhang Y., and Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 5 (2009) 707-713
45. Gurevich O., Vexler A., Marx G., Prigozhina T., Levdansky L., Slavin S., et al. Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Eng 8 4 (2002) 661-672
46. Zhu S.J., Choi B.H., Jung J.H., Lee S.H., Huh J.Y., You T.M., et al. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2 (2006) 175-179
47. Ito K., Yamada Y., Naiki T., and Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 17 5 (2006) 579-586
48. Everts P.A., van Zundert A., Schonberger J.P., Devilee R.J., and Knape J.T. What do we use: platelet-rich plasma or platelet-leukocyte gel?. J Biomed Mater Res A 85 4 (2008) 1135-1136
49. Cieslik-Bielecka A., Gazdzik T.S., Bielecki T.M., and Cieslik T. Why the platelet-rich gel has antimicrobial activity?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 3 (2007) 303-305 [author reply 5-6]
50. Moojen D.J., Everts P.A., Schure R.M., Overdevest E.P., van Zundert A., Knape J.T., et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 26 3 (2008) 404-410
51. El-Sharkawy H., Kantarci A., Deady J., Hasturk H., Liu H., Alshahat M., et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 78 4 (2007) 661-669
52. Italiano Jr. J.E., Richardson J.L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111 3 (2008) 1227-1233
53. Maria O.M., Khosravi R., Mezey E., and Tran S.D. Cells from bone marrow that evolve into oral tissues and their clinical applications. Oral Dis 13 1 (2007) 11-16
54. Igarashi A., Segoshi K., Sakai Y., Pan H., Kanawa M., Higashi Y., et al. Selection of common markers for bone marrow stromal cells from various bones using real-time RT-PCR: effects of passage number and donor age. Tissue Eng 13 10 (2007) 2405-2417
55. Ng A.M., Saim A.B., Tan K.K., Tan G.H., Mokhtar S.A., Rose I.M., et al. Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Orthop Sci 10 2 (2005) 192-199